Search This Blog

Monday, October 5, 2026

Alector grants Genentech exclusive global license to therapy for $100M upfront plus up to $1.17B milestones

 


  • Genentech receives worldwide rights to AL050 under the exclusive global licensing agreement with Alector
  • Deal terms include tiered royalties payable to Alector on future net sales of AL050
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)